Nanomedicines for Therapy of Bladder Cancer

Bladder cancer is one of most common malignant urinary tract tumor types, and transurethral resection nonmuscle invasive bladder followed by intravesical instillation immunochemotherapy the standard treatment approach to minimize recurrence delay progression cancer. In general, conventional lacks selectivity for tissues effect drug reduced with excretion urine leading frequent administration irritation symptoms. Recently, nanomedicines which adhere tumors a long time, continuously efficiently release cancers may overcome all above problems. Moreover, advances in nanomedicine based targeted therapy have led significant improvements efficacy precision delivery. This review shows available nano-systems delivery tissues.